Brain‑Computer Interface Stocks Surge as China Launches Clinical Trial

Hong Kong’s brain‑computer interface concept stocks rallied strongly on May 19, with Brain Aurora‑B soaring more than 42%, MicroPort NeuroTech up 7%, and Nanjing Panda Electronics rising over 6%. The surge followed news that China has launched its first multi‑center clinical trial of a 128‑channel fully implantable brain‑computer interface system, led by Beijing Tiantan Hospital. The trial marks a breakthrough in invasive brain‑computer interface technology and lays the groundwork for commercialization.

The system combines intracortical flexible electrodes made of ultra‑thin biocompatible materials with a fully implantable signal collector. The design reduces immune response and enables high‑resolution capture of single‑neuron activity. This allows real‑time, precise decoding of brain signals and dramatically increases information transmission rates, providing reliable support for clinical use.

Earlier, regulators approved Boruikang Medical Technology’s implantable brain‑computer interface product for hand motor function compensation. Institutions say the industry is now at a turning point from lab breakthroughs to commercialization. BOC International noted rapid progress across three technical paths, with upstream components facing high barriers and downstream medical applications offering the largest market. With policy support, commercialization is accelerating and the market could grow from tens of billions to hundreds of billions of yuan.

Huajin Securities said 2026 will be a pivotal year, with policy, technology, and clinical advances combining to drive growth. Non‑invasive technology is moving quickly into consumer markets thanks to safety and low cost, while invasive and semi‑invasive approaches are targeting high‑value medical scenarios. Huayuan Securities added that the 15th Five‑Year Plan provides a national framework for commercialization, concentrating resources, supporting pilot projects, and leveraging capital markets to push brain‑computer interface technology toward large‑scale application.